Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 4,257 | 4,455 | 4,642 | 4,760 |
| Other current assets | 0 | 2,630 | 2,375 | 3,265 | 4,406 |
| TOTAL | $N/A | $6,887 | $6,830 | $7,907 | $9,166 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 382 | 382 | 382 | 382 |
| TOTAL | $N/A | $382 | $382 | $382 | $382 |
| Total Assets | $N/A | $7,269 | $7,212 | $8,289 | $9,548 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 244 | 232 | 0 | 0 |
| TOTAL | $N/A | $244 | $232 | $200 | $203 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $244 | $232 | $200 | $203 |
| Shareholders' Equity | |||||
| Other shareholders' equity | 0 | 7,025 | 6,980 | 8,089 | 9,345 |
| TOTAL | $N/A | $7,025 | $6,980 | $8,089 | $9,345 |
| Total Liabilities And Equity | $0 | $7,269 | $7,212 | $8,289 | $9,548 |